Joseph Monahan
Chief Tech/Sci/R&D Officer presso ACLARIS THERAPEUTICS, INC.
Patrimonio netto: 231 850 $ in data 31/03/2024
Posizioni attive di Joseph Monahan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - | - |
Aclaris Life Sciences, Inc.
 Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Director/Board Member | 01/01/2010 | - |
| Chief Tech/Sci/R&D Officer | 01/01/2010 | - | |
| Founder | 01/01/2010 | - |
Storia della carriera di Joseph Monahan
Precedenti posizioni note di Joseph Monahan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Formazione di Joseph Monahan
| State University of New York at Buffalo | Undergraduate Degree |
| University of South Carolina | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Aclaris Life Sciences, Inc.
Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Health Services |
- Borsa valori
- Insiders
- Joseph Monahan
- Esperienza
